Related Experiment Video
Updated: Dec 6, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Proteasomal degradation of polycomb-group protein CBX6 confers MMP-2 expression essential for mesothelioma invasion
Katsuya Sakai1,2, Takumi Nishiuchi3, Shoichiro Tange4
1Division of Tumor Dynamics and Regulation, Cancer Research Institute, Kanazawa University, Kanazawa, 920-1192, Japan. k_sakai@staff.kanazawa-u.ac.jp.
Abstract:
The aggressive invasiveness of malignant mesothelioma limits cancer therapy, however, the molecular mechanisms underlying the invasiveness remain largely unknown. Here we found that the matrix metalloproteinase-2 (MMP-2) was required for the invasion of mesothelioma cells in the collagen matrix and the gene expression of MMP-2 was correlated with the invasive phenotype. The MMP-2 gene expression was regulated by DNA and histone methylation around the transcription start site, implicating the involvement of the polycomb repressive complex (PRC). Knockdown of PRC component chromobox 6 (CBX6) promoted MMP-2 expression and invasion of mesothelioma cells. Transcriptome analysis suggested that CBX6 regulates sets of genes involved in cancer cell migration and metastasis. In invasive but not non-invasive cells, CBX6 was constantly unstable owing to ubiquitination and protein degradation. In human tissues, CBX6 localized in the nuclei of normal mesothelium and benign mesothelioma, but the nuclear staining of CBX6 was lost in malignant mesothelioma. These results suggest involvement of proteasomal degradation of CBX6 in mesothelioma progression.
Insights
Chromobox 6 (CBX6) instability promotes malignant mesothelioma invasion by increasing matrix metalloproteinase-2 (MMP-2) expression. Loss of nuclear CBX6 in malignant mesothelioma suggests its proteasomal degradation drives cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Malignant mesothelioma's aggressive invasiveness poses challenges for cancer therapy.
- The molecular mechanisms driving mesothelioma invasiveness are not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying malignant mesothelioma invasiveness.
- To investigate the role of Polycomb Repressive Complex (PRC) components in mesothelioma progression.
Main Methods:
- Correlation analysis of matrix metalloproteinase-2 (MMP-2) gene expression with invasive phenotype.
- Investigating MMP-2 regulation by DNA and histone methylation.
- Chromobox 6 (CBX6) knockdown and transcriptome analysis.
- Assessment of CBX6 protein stability via ubiquitination and degradation assays.
- Immunohistochemical analysis of CBX6 expression in human tissues.
Main Results:
- MMP-2 expression is crucial for mesothelioma cell invasion and correlates with invasiveness.
- MMP-2 gene expression is epigenetically regulated by methylation, involving PRC.
- CBX6 knockdown enhances MMP-2 expression and mesothelioma cell invasion.
- CBX6 regulates genes associated with cancer cell migration and metastasis.
- CBX6 is unstable in invasive cells due to proteasomal degradation and is lost in malignant mesothelioma tissues.
Conclusions:
- Epigenetic regulation of MMP-2 by CBX6 is a key mechanism in mesothelioma invasiveness.
- Proteasomal degradation of CBX6 contributes to mesothelioma progression.
- CBX6 loss is a potential biomarker for malignant mesothelioma.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Role of Matrix Metalloproteases in Degradation of ECM
Master Transcription Regulators
The Intrinsic Apoptotic Pathway
Epigenetic Regulation
Caspases

